Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
587 Leser
Artikel bewerten:
(2)

Li-Metal Begins Trading on the Canadian Securities Exchange

Finanznachrichten News

Next Generation Battery Technology Disrupter to Trade under the Ticker "LIM" on the CSE

TORONTO, ON / ACCESSWIRE / November 3, 2021 / Li-Metal Corp. (CSE:LIM) ("Li-Metal" or the "Company"), a leading developer of scalable lithium anode and lithium metal technologies critical for next generation batteries, announces that, as of today, November 3, 2021, the common shares of the Company will begin trading on the Canadian Securities Exchange (the "CSE") under the ticker "LIM".

Founded in Toronto by Maciej Jastrzebski, the Chief Executive Officer of Li-Metal and Tim Johnston, a director of Li-Metal and the Co-Founder and Executive Chairman of Li-Cycle Corp., Li-Metal addresses a pressing underlying technology trend in global electrification - the development and adoption of next generation batteries. It is imperative that the battery supply chain adapts as the world transitions from conventional lithium-ion batteries to next generation batteries.

"We are thrilled to make our debut as a publicly traded Canadian company on the CSE and are positioned to scale our breakthrough metallic lithium anode and metal production technologies," said Mr. Jastrzebski. "Producing next generation batteries for electric vehicles with existing technologies can be costly, as they use more lithium than needed and the production costs are high. By utilizing Li-Metal's technologies, battery cell manufacturers and original equipment manufacturers will be able to produce advanced batteries with less lithium, reducing the need for a finite resource, powering more cost-effective, longer range and safer electric vehicles."

Li-Metal sits at the epicenter of three heavy macroeconomic trends: the need to support the mass adoption of next generation batteries, a North American supply shortage of critical battery materials and the need for environmentally friendly solutions supporting the electric vehicle revolution. Li-Metal is developing two scalable, cost effective, safe and sustainable technologies that address these core megatrends:

  • Lithium Anode Technology - low-cost, high performance, and highly scalable technology for producing lithium metal anodes for next generation batteries.
  • Lithium Metal Technology - an improved lithium metal production process utilizing abundantly available chemical sources that eliminates lithium chloride, produces no toxic chlorine off-gas and minimal emissions.

Retains Investor Relations Consultant

Li-Metal is also pleased to announce that it has retained Target IR & Communications ("Target IR"), a full-service investor relations consultancy based in Toronto. Target IR will provide investor relations services for the Company with the aim of increasing Li-Metal's visibility in the investment community and will engage with analysts and investors and communicate key events to shareholders.

Target IR will provide investor relations services to Li-Metal for a 12-month period and will be paid C$8,000 on a monthly basis, exclusive of applicable taxes and certain expenses incurred. Target IR will also be granted options to purchase up to 20,000 common shares of the Company, half of which will vest and become exercisable 12 months after the date of issuance, the other half of which will vest and become exercisable 24 months after the date of issuance.

About Li-Metal Corp.

Li-Metal is a Canadian-based company developing lithium metal anodes and lithium metal production technologies for use in next generation batteries. Our production methods are significantly more sustainable than existing products and offer lighter, more energy dense and safer batteries that are critical to tomorrow's electric vehicles. For more information visit, www.li-metal.com.

Forward-Looking Information

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "believes", "projects", "plans" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's strategic plans are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the development of the business of the Company will be completed as described above. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Investor Contact
Salisha Ilyas
ir@li-metal.com

Media Contact
Harry Nicholas
Li-MetalPR@icrinc.com

SOURCE: Li-Metal



View source version on accesswire.com:
https://www.accesswire.com/670891/Li-Metal-Begins-Trading-on-the-Canadian-Securities-Exchange

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.